Gabrielle Brossard

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. Serradeil‐Le Gal, C Lacour, G Valette et al. · Journal of Clinical Investigation · 1996 · 247 citations · Full text

Molecular Pharmacology, Selective Affinity, Arginine Vasopressin +14

Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 207 citations · Full text

Characterization and localization of leptin receptors in the rat kidney

Claudine Serradeil‐Le Gal, Danièle Raufaste, Gabrielle Brossard et al. · FEBS Letters · 1997 · 116 citations · Full text

Cold Leptin, Renal Inflammation, Gastrointestinal Peptide Hormone +16

SR120819A, an orally‐active and selective neuropeptide Y Y1 receptor antagonist

Claudine Serradeil‐Le Gal, Gérard Valette, Pierre-Eric Rouby et al. · FEBS Letters · 1995 · 112 citations · Full text

Molecular Pharmacology, Sr 120819A, Biochemistry +15

Pharmacological and Physiological Characterization of d[Leu4, Lys8]Vasopressin, the First V1b-Selective Agonist for Rat Vasopressin/Oxytocin Receptors

Ana Peña, Brigitte Murat, Miguel Trueba et al. · Endocrinology · 2007 · 32 citations · Full text

Vp Receptor, Pharmacotherapy, First V1b-selective Agonist +20